BioLASCO Taiwan Co., Ltd.

TPEX:6662 Stock Report

Market Cap: NT$891.3m

BioLASCO Taiwan Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenure1.5yrs

Recent management updates

Recent updates

We Think You Should Be Aware Of Some Concerning Factors In BioLASCO Taiwan's (GTSM:6662) Earnings

Apr 01
We Think You Should Be Aware Of Some Concerning Factors In BioLASCO Taiwan's (GTSM:6662) Earnings

Are BioLASCO Taiwan Co., Ltd.'s (GTSM:6662) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?

Mar 11
Are BioLASCO Taiwan Co., Ltd.'s (GTSM:6662) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?

Investors In BioLASCO Taiwan Co., Ltd. (GTSM:6662) Should Consider This, First

Feb 10
Investors In BioLASCO Taiwan Co., Ltd. (GTSM:6662) Should Consider This, First

Is BioLASCO Taiwan (GTSM:6662) A Risky Investment?

Jan 08
Is BioLASCO Taiwan (GTSM:6662) A Risky Investment?

BioLASCO Taiwan Co., Ltd.'s (GTSM:6662) Stock Has Shown A Decent Performance: Have Financials A Role To Play?

Dec 10
BioLASCO Taiwan Co., Ltd.'s (GTSM:6662) Stock Has Shown A Decent Performance: Have Financials A Role To Play?

CEO

BioLASCO Taiwan has no CEO, or we have no data on them.

Board Members

NamePositionTenureCompensationOwnership
Ming-Chieh Chen
Independent Director1.5yrsno datano data
Chen-Chung Chen
Chairman of the Board1.5yrsno data14.32%
NT$ 127.6m
Li-Chu Wu
Director1.5yrsno data4.68%
NT$ 41.7m
Chun-Wei Chen
Director1.5yrsno data0.37%
NT$ 3.3m
Wei-Ming Liu
Director1.5yrsno data0.25%
NT$ 2.2m
Han-Tan Cheng
Independent Director1.5yrsno datano data
Feng-Ji Cheng
Independent Director1.5yrsno datano data

1.5yrs

Average Tenure

Experienced Board: 6662's board of directors are not considered experienced ( 1.5 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/18 13:11
End of Day Share Price 2024/12/18 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

BioLASCO Taiwan Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution